CorVel Corporation

NasdaqGS:CRVL Voorraadrapport

Marktkapitalisatie: US$5.2b

CorVel Inkomsten in het verleden

Verleden criteriumcontroles 5/6

CorVel is de winst gegroeid met een gemiddeld jaarlijks percentage van 12.5%, terwijl de Healthcare industrie de winst jaarlijks groeide met 5.4%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 7.6% per jaar. Het rendement op eigen vermogen van CorVel is 29.6%, en het heeft een nettomarge van 9.6%.

Belangrijke informatie

12.5%

Groei van de winst

14.3%

Groei van de winst per aandeel

Healthcare Groei van de industrie8.5%
Inkomstengroei7.6%
Rendement op eigen vermogen29.6%
Nettomarge9.6%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Subdued Growth No Barrier To CorVel Corporation's (NASDAQ:CRVL) Price

Oct 22
Subdued Growth No Barrier To CorVel Corporation's (NASDAQ:CRVL) Price

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Aug 27
Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

Jul 30
Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

Jul 12
CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 25
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Apr 07
CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

Mar 19
Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Jan 10
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

Dec 23
The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

Dec 05
With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Oct 10
CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Sep 01
Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

Jul 10
We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 11
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

Mar 24
If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Jan 06
A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

Dec 19
Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

Sep 21
CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

Aug 25
We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

CorVel GAAP EPS of $0.94, revenue of $176M

Aug 02

Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Jun 23
Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

May 18
Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

Mar 21
CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Feb 14
With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Opbrengsten en kosten

Hoe CorVel geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NasdaqGS:CRVL Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2481778800
31 Mar 2479576770
31 Dec 2377475750
30 Sep 2375175730
30 Jun 2373369710
31 Mar 2371966740
31 Dec 2270468710
30 Sep 2269065710
30 Jun 2267066700
31 Mar 2264666680
31 Dec 2162062670
30 Sep 2159759670
30 Jun 2157655660
31 Mar 2155346640
31 Dec 2055443640
30 Sep 2056141640
30 Jun 2057242650
31 Mar 2059247650
31 Dec 1959647660
30 Sep 1959448650
30 Jun 1959548630
31 Mar 1959647630
31 Dec 1858844620
30 Sep 1858343620
30 Jun 1857139610
31 Mar 1855836590
31 Dec 1754835590
30 Sep 1753632570
30 Jun 1752831580
31 Mar 1751929570
31 Dec 1651328580
30 Sep 1650928580
30 Jun 1650529570
31 Mar 1650429580
31 Dec 1549727560
30 Sep 1549628560
30 Jun 1549527550
31 Mar 1549329540
31 Dec 1449131540
30 Sep 1448933540
30 Jun 1448534530
31 Mar 1447934520
31 Dec 1347134500

Kwaliteitswinsten: CRVL heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (9.6%) CRVL } zijn hoger dan vorig jaar (9.5%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van CRVL is de afgelopen 5 jaar met 12.5% per jaar gegroeid.

Versnelling van de groei: De winstgroei van CRVL over het afgelopen jaar ( 12.3% ) ligt onder het 5-jarig gemiddelde ( 12.5% per jaar).

Winst versus industrie: De winstgroei CRVL over het afgelopen jaar ( 12.3% ) overtrof de Healthcare -sector 11.4%.


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 29.6% ) van CRVL wordt als hoog beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden